Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety

Background: Seroconversion and longevity of vaccine-induced immune response is blunted in immune-mediated inflammatory disease (IMID) patients owing to immunosuppressive regimens. COVID-19 booster vaccines after a primary series have been proposed with inconclusive evidence on efficacy to date. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ainsley Ryan Yan Bin, Wong, Shi Yin, Tay, Sen Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144569/
https://www.ncbi.nlm.nih.gov/pubmed/35632424
http://dx.doi.org/10.3390/vaccines10050668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144569/
https://www.ncbi.nlm.nih.gov/pubmed/35632424
http://dx.doi.org/10.3390/vaccines10050668

Ejemplares similares